At the University of Arizona Cancer Center, Banner University Medical Center Tucson, a multidisciplinary team of physicians, pharmacy staff, finance specialists, social workers, nursing staff, and information technologists first identified chemotherapy regimens administered in the inpatient setting that could be safely administered in the outpatient setting, and then implemented a transition plan that included provider and patient education. Benefits included reduced inpatient medical resources and chemotherapy costs, decreased inpatient bed stay, lower infection rates, improved quality of life, and decreased overall cost of care—conservatively estimated at almost $6 million.
To hear this ACCC Innovator Award session on-demand, please visit the ACCC eLearning portal.
To improve patient care and reduce overall costs, the University of Arizona Cancer Center at Banner University Medical Center in Tucson transitioned to delivering select chemotherapies in its ambulatory clinics. Doing so took a significant coordinated effort. The task of assessing which chemotherapies could be safely administered in the outpatient setting took a multidisciplinary team a full year. The team then developed workflows for each chemotherapy to be administered in outpatient clinics and educated staff about the relevant chemotherapies’ potential side effects and toxicities. A year and a half after launching the effort, the University of Arizona Cancer Center transitioned to administering select chemotherapy its ambulatory clinics, reducing overnight hospital stays and lowering costs to patients and the health system.”
Read Full Story
UArizona Cancer Center Honored with 2020 Innovator Award
Sep 14, 2020
Latest Innovations in Cancer Care Delivery Unveiled at the ACCC’s 37th (Virtual) National Oncology Conference
Aug 26, 2020